General Information of the Compound
Compound ID
CP0254388
Compound Name
5-Methoxy-9-oxo-9,10-dihydro-acridine-4-carboxylic acid {4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-amide
    Show/Hide
Synonyms
143851-98-3
4CA-0489
7066AA
AC-30266
AC1L55DX
AC1Q3EOG
ACN-041487
AKOS016005297
AOB5938
BCP14056
C34H34ClN3O5
CHEMBL2074730
CS-1113
D03968
Elacridar
Elacridar (hydrochloride)
Elacridar HCl
Elacridar hydrochloride
Elacridar hydrochloride (USAN)
Elacridar hydrochloride [USAN]
FT-0696337
GF 120918
GF-120918A
HY-50880
MolPort-023-332-877
N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide hydro
NX2BHH1A5B
SCHEMBL15847793
UNII-NX2BHH1A5B
W-5457
gf 120918a
    Show/Hide
Structure
Formula
C34H33N3O5
Molecular Weight
563.654
Canonical SMILES
COc1cc2CCN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(OC)cccc4c5=O)cc3)Cc2cc1OC
    Show/Hide
InChI
InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)
    Show/Hide
InChIKey
OSFCMRGOZNQUSW-UHFFFAOYSA-N
CAS
143664-11-3
Physicochemical Property
logP
5.5602
Rotatable Bonds
8
Heavy Atom Count
42
Polar Areas
92.89
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
42

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 119373
SID: 14935336
ChEMBL ID
CHEMBL396298
DrugBank ID
DB04881
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000034 Caco-2 Homo sapiens (Human)  2
1
EC50 = 2000 nM
   TI
   LI
   LO
   TS
2
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CL000356 KB-V1 Homo sapiens (Human)  1
1
IC50 = 193 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 4.9 nM
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000781 MCF7/Topo Homo sapiens (Human)  2
1
IC50 = 127 nM
   TI
   LI
   LO
   TS
2
IC50 = 250 nM
   TI
   LI
   LO
   TS
CL000756 MCF/MX Homo sapiens (Human)  1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 410 nM
   TI
   LI
   LO
   TS
CL000031 MDCK Canis lupus familiaris (Dog)  1
1
IC50 = 430 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 252.2 nM
Clinical Information about the Compound
Drug 1 ( Elacridar )
Drug Name Elacridar
Indication
Solid tumour/cancer
Discontinued in Phase 1
Target(s)
Multidrug resistance protein 1 (ABCB1)
Inhibitor